Information Recovery in a Study With Surrogate Endpoints
نویسندگان
چکیده
Recently, there has been a lot of interest in statistical methods for analyzing data with surrogate endpoints. In this article, we consider parameter estimation from a model that relates a variable Y to a set of covariates, X, in the presence of a surrogate, S. We assume that the data are made up of two random samples from the population, a validation set where (Y,X,S) are observed on every subject and a nonvalidation set where only (X,S) are measured. We show how information from the nonvalidation set can be incorporated to improve upon estimation of a parameter β using the validation data only. The method we suggest does not require knowledge on the joint distribution between (Y,S), given X. It is based on a two-sample empirical likelihood that simultaneously combines the estimating equations from the validation set and the nonvalidation set. The proposed nonparametric likelihood formulation brings a few attractive features to the inference in β. First, the maximum empirical likelihood estimate is more efficient than that using only the validation sample. Second, confidence regions can be readily constructed without the need to estimate the variance-covariance matrix. Finally, the coverage of the confidence regions can be further improved by an empirical Bartlett correction based on the bootstrap. We show that the method gives favorable results in simulation studies.
منابع مشابه
Defining Surrogate Endpoints for Clinical Trials in Severe Falciparum Malaria
BACKGROUND Clinical trials in severe falciparum malaria require a large sample size to detect clinically meaningful differences in mortality. This means few interventions can be evaluated at any time. Using a validated surrogate endpoint for mortality would provide a useful alternative allowing a smaller sample size. Here we evaluate changes in coma score and plasma lactate as surrogate endpoin...
متن کاملUse of Surrogate end points in HTA
The different actors involved in health system decision-making and regulation have to deal with the question which are valid parameters to assess the health value of health technologies.So called surrogate endpoints represent in the best case preliminary steps in the casual chain leading to the relevant outcome (e. g. mortality, morbidity) and are not usually directly perceptible by patients. S...
متن کاملBayesian meta‐analytical methods to incorporate multiple surrogate endpoints in drug development process
A number of meta-analytical methods have been proposed that aim to evaluate surrogate endpoints. Bivariate meta-analytical methods can be used to predict the treatment effect for the final outcome from the treatment effect estimate measured on the surrogate endpoint while taking into account the uncertainty around the effect estimate for the surrogate endpoint. In this paper, extensions to mult...
متن کاملInformation theory-based surrogate marker evaluation from several randomized clinical trials with binary endpoints, using SAS.
One of the paradigms for surrogate marker evaluation in clinical trials is based on employing data from several clinical trials: the meta-analytic approach. It was originally developed for continuous outcomes by means of the linear mixed model, but other situations are of interest. One such situation is when both outcomes are binary. Although joint models have been proposed for this setting, th...
متن کاملOutcome Measures in Relapsing-Remitting Multiple Sclerosis: Capturing Disability and Disease Progression in Clinical Trials
Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease that manifests as acute relapses and progressive disability. As a primary endpoint for clinical trials in MS, disability is difficult to both characterize and measure. Furthermore, the recovery from relapses and the rate of disability vary considerably among patients. Given these challenges, investigators have devel...
متن کامل